コンテンツへスキップ
Merck
  • Dose proportionality study of loperamide following oral administration of loperamide oxide.

Dose proportionality study of loperamide following oral administration of loperamide oxide.

European journal of clinical pharmacology (1992-01-01)
F Kamali, L Adriaens, M L Huang, R Woestenborghs, M Emanuel, M D Rawlins
要旨

The pharmacokinetics of loperamide, after oral administration of increasing doses (1 to 16 mg) of loperamide oxide, has been investigated in 10 healthy male volunteers, using a randomised cross-over design. Comparison of the maximum plasma loperamide concentration and AUC demonstrated that the bioavailability of loperamide was proportional to the dose of loperamide oxide administered.

材料
製品番号
ブランド
製品内容

Loperamide oxide monohydrate, European Pharmacopoeia (EP) Reference Standard